Short Term Technical Adviser for the CTB Vietnam Project

USAID ChallengeTB KNCV logo

KNCV Vietnam is looking for a:

Short Term Technical Adviser for the CTB Vietnam Project

Clinical training on BDQ

Duty station: Vietnam

KNCV Tuberculosis Foundation
KNCV Tuberculosis Foundation is an international non-profit organization dedicated to the fight against tuberculosis (TB), still the second most deadly infectious disease in the world.
KNCV is an international center of expertise for TB control that promotes effective, efficient, innovative and sustainable tuberculosis control strategies in a national and international context. We are an organization of passionate TB professionals, including doctors, researchers, training experts, nurses and epidemiologists. We aim to stop the spread of the worldwide epidemic of TB and to prevent the further spread of drug-resistant TB.
Over the past century we have built up a wealth of knowledge and expertise, initially by successfully controlling TB in the Netherlands. Since the 1970s, we have also shared our knowledge and expertise with the rest of the world. We operate from a central office in The Hague in the Netherlands, a regional office in Central Asia and country offices worldwide. KNCV raises funds from private, institutional, corporate, and government donors.
Challenge TB
KNCV Tuberculosis Foundation is an international non-profit organization dedicated to the fight against tuberculosis (TB), still the second most deadly infectious disease in the world. KNCV is the lead partner in Challenge TB (CTB), the new USAID-funded 5-year global program to decrease TB mortality and morbidity in high burdened countries. We lead an international consortium with eight partner organizations: American Thoracic Society (ATS), Family Health International (FHI 360), Interactive Research & Development (IRD), Japanese Anti Tuberculosis Foundation (JATA), Management Sciences for Health (MSH), Program for Appropriate Technology in Health (PATH), The International Union Against Tuberculosis and Lung Disease (The Union), and the World Health Organization.

Purpose of the assignment
The primary aim of the assignment is to conduct a training on new (BDQ) and repurposed drugs-containing regimens in treatment for MDR/XDR-TB.

In particular the Consultant is expected:

  • To share experiences in the introduction and scale up of Bedaquiline (BDQ) containing regimens, particularly challenges and lessons learned
  • To participate in field visits as introduction to the Vietnam PMDT program and the status of the use of BDQ and repurposed drugs
  • To conduct patient chart reviews, and facilitate discussions on treatment decisions, and provide recommendations on difficult cases
  • To attend one Clinical Review Committee/DR-TB Task Force meeting and participate in discussions, with recommendations on presented cases guided by recommended principles
  • To conduct a clinical training among members of the national Drug-resistant TB Task Force and staff of MDR treatment centers on the use of BDQ containing regimens particularly:
    • on regimen design and the use of repurposed drugs, such as Linezolid, Clofazimine, other second line drugs, clinical monitoring of patients, management of adverse drug reactions, regimen change, determination of treatment outcome, and post-treatment monitoring;
    • on the eligibility criteria, and provide examples of the use of BDQ in special populations such as children, TB/HIV co-infected, pregnant women, and clinically difficult cases: pre-XDR, XDR, patients with co-morbidities;
    • on active drug safety management and monitoring, including the package used.
  • To share views on the use of Delamanid, and preparations for its introduction, etc.


  • Training conducted on BDQ for 20-25 staff of NTPs of Vietnam, Indonesia, India, Myanmar and Cambodia (CAM – to be confirmed)

The Consultant operates under the supervision of the Country Director and reports directly to the Country Director. Within one working week a Summary Mission Report on the training is shared with the Country Director for approval and should be shared with KNCV HQ for final approval.

5 days preparation and reporting, 15 days in-country
The assignment begins on 19th September 2016

Hanoi, Vietnam and field visits to Hanoi, Ho Chi Minh City and Can Tho

Qualifications below are essential:

  • A Clinical working medical doctor with at least 10 years of experience in caring for patients with TB, TBHIV and MDR TB
  • Extensive hands-on experience with the use of new (BDQ, DLM) and repurposed drugs in the treatment of pre-XDR and XDR patients


  • A consultancy contract for the duration of the assignment
  • An international environment where initiative is appreciated
  • A fee that is competitive for the scope of the assignment.

Application and information
Your application (Curriculum Vitae, proof of experience and proficiency in the stated assignment) should be sent before 1st August to:
Jan Willem Dogger, email, under subject “Vietnam BDQ training”. For further information about KNCV Tuberculosis Foundation, please see